A Dosing Study of Intravitreal Bevacizumab for Retinopathy of Prematurity
NCT05712642
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Retinopathy of Prematurity
Interventions
DRUG:
Intravitreal Bevacizumab
Sponsor
Cairo University